Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Rifapentine

U.S. FDA Requirements: Rifapentine

Pharmaceutical / Drug Definition : Inhibits RNA synthesis by blocking RNA transcription in susceptible organisms (mycobacteria and some gram-positive and gram-negative bacteria

In the United States, Rifapentine is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Rifapentine.

Registrar Corp assists Rifapentine companies with:

  • FDA Registration Rifapentine
  • FDA Listing Rifapentine
  • FDA Label Requirements and Exceptions Rifapentine
  • FDA Import Information Rifapentine
  • FDA Detentions Rifapentine (Rifapentine Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Rifapentine (Rifapentine Suppliers)
       - Processors Rifapentine
       - Repackers Rifapentine
       - Relabelers Rifapentine
       - Exporters Rifapentine
       - Importers Rifapentine
For more information about Rifapentine, simply click below:

Live Help

U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207

Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2017 Registrar Corp
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco